The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab/ipilimumab primed immunotransplant in post-CAR-T and post-ASCT DLBCL.
 
Bailey Gleason Fitzgerald
No Relationships to Disclose
 
Thomas Urban Marron
Consulting or Advisory Role - AstraZeneca; Atara Biotherapeutics; Boehringer Ingelheim; Genentech; Regeneron
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Atara Biotherapeutics (Inst); Genentech
 
Dana Ostrowski
No Relationships to Disclose
 
Jonah Shulman
Consulting or Advisory Role - Seagen
 
Matko Kalac
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Fortress Biotech
Research Funding - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Columbia University
Travel, Accommodations, Expenses - Curio Science
 
Netonia Marshall
No Relationships to Disclose
 
Joshua Brody
Research Funding - Acerta Pharma; Bristol Myers Squibb Foundation; Celgene; Janssen; Kite, a Gilead Company; Merck; MorphoSys; Seagen; Takeda